Introduction {#s1}
============

Biofilms are highly structured communities of immobile microorganisms that are adhered to a surface or to each other, and embedded in a protective extracellular polymeric matrix consisting of polysaccharides, nucleic acids, proteins, and lipids (Flemming et al., [@B14]). Biofilms are frequently found on natural, clinical and industrial settings, causing tremendous issues due to the fact that they are resistant to external stresses, host defenses and conventional antimicrobial agents (de la Fuente-Núñez et al., [@B8]). For example, biofilms represent major virulence factors, resulting in chronic human infections, implant failure and even death (Anderson et al., [@B1]; Duncan et al., [@B10]). Also, biofilms are harmful for industrial facilities by blocking filtration membranes, fouling marine surfaces, or corroding pipes (Natalio et al., [@B37]). However, combating these biofilms, by either prevention or eradication, remains particularly challenging in both industrial and biomedical applications.

Annihilation of biofilm *in vivo* with traditional therapeutic antibiotics is becoming an overwhelming task. Antimicrobial therapy alone is rarely effective, and surgical intervention is often needed, resulting in a prolonged course of medical treatment with high costs (Kostakioti et al., [@B25]). Even worse, the development of new antibiotics is slow and difficult, which cannot keep pace with the emergence of antibiotic-resistant microorganisms (Fischbach and Walsh, [@B13]). Thus, alternative strategies to combat biofilm are highly desired. With the rapid development of nanotechnology, an increasing number of nanomaterials with unique properties have been explored for fighting various biofilms. Such nanomaterials include metal/metal oxide nanoparticles (Taglietti et al., [@B46]; Boda et al., [@B4]; Nguyen et al., [@B38]; Geilich et al., [@B16]; Hu et al., [@B19]) along with polymeric nanoparticles (Duong et al., [@B11]; Nguyen et al., [@B39]), nanoparticle-stabilized capsules (Duncan et al., [@B10]), nanoenzymes (Natalio et al., [@B37]; Chen et al., [@B5]), hydrogels(Gao et al., [@B15]), liposomes (Robinson et al., [@B45]) and so on, in either antibiotic-free or antibiotic-coated ways. A big concern with the application of nanomaterials in killing biofilm is cytotoxicity which was also often observed in many conventional antibiofilm materials. Despite their excellent anti-biofilm activity, nanomaterials are usually toxic toward microorganisms and human cells, and are consequently not biocompatible (Hu et al., [@B19]). This non-biocompatibility issue caused safety concerns, decreased therapeutic selectivity, and adverse effects on ecosystems, and thus needs to address urgently. To solve this problem, surface engineering is routinely explored to finely tune nanomaterials\' surface properties to achieve concurrent antibiofilm activity and non-cytotoxicity, which nevertheless involves the use of complex chemical/physical modification methods (Giri et al., [@B17]; Hu et al., [@B19]).

In this study, we present a novel type of carbon dots, easily prepared using *L. plantarum* as a single carbon source by one-step hydrothermal reaction without any chemical/physical modification, to prevent *E. coli* biofilm formation with excellent biocompatibility (Scheme [1](#SC1){ref-type="scheme"}). Carbon dots have wide applications in many fields including sensing, bio-imaging, photo-catalysis, drug delivery, etc., because of their facile synthesis route, exceptional photostability, low toxicity, great water dispersibility and amenable surface modification (Li et al., [@B31]; Wang and Hu, [@B48]). They have been successfully employed to discriminate gram negative/positive bacteria (Yang et al., [@B50]) as well as live/dead microorganisms (Hua et al., [@B21]). The amphiphilic carbon dots have been synthesized and utilized for efficiently labeling biomimetic and cellular membranes (Nandi et al., [@B35], [@B36]). Furthermore, carbon dots usually possess varied surface functional groups and can be easily engineered by other drugs and ligands for the applications in organelle-targeted imaging and/or drug delivery (Yang et al., [@B51]; Zhang et al., [@B54]; Hua et al., [@B20]). For biofilm application, carbon dots have been successfully exploited to image biofilm matrix (Ritenberg et al., [@B44]) and biofilm-encased microorganisms (Lin et al., [@B33]). However, to the best of our knowledge, the utilization of carbon dots in combating biofilm has not been reported.

![Schematic of the synthetic route and anti-biofilm of CDs-LP.](fmicb-09-00259-g0006){#SC1}

Materials and methods {#s2}
=====================

Preparation and purification of CDs
-----------------------------------

CDs-LP were made from *L. plantarum* LLC-605 by one-step hydrothermal carbonization. *L. plantarum* LLC-605 was isolated in our lab from the traditional Chinese fermented food FuYuan pickles (Yunnan, China), which was deposited in NCBI with the accession number [KX443590](KX443590) (Li et al., [@B30]). *L. plantarum* LLC-605 was cultured in 30 mL De Man, Rogosa and Sharpe (MRS) medium at 31°C for 18 h without shaking. The overnight cell culture was centrifuged at 5,000 rpm for 10 min to remove the supernatant, washed three times with Milli-Q water, and transferred into a 50 mL Teflon-lined stainless-steel autoclave, and re-suspended in 30 mL Milli-Q water. The autoclave was incubated at 200°C for 24 h. To remove large particles/aggregates, the synthesized dark brown solution was centrifuged at 12,000 rpm for 10 min, and the supernatant was filtered through a 0.22 μm filter membrane. Then, the CD solution was dialyzed against Milli-Q water in a dialysis bag with molecular weight cut-off of 1 kDa for 2 days, and stored at 4°C for further experiments. For quantification and long-term storage, the CDs were lyophilized and weighed after dialysis.

Characterizations of CDs
------------------------

The morphology, size and element components of the as-synthesized CDs-LP were determined. A drop of CDs-LP solution was deposited on a 400-mesh carbon-coated copper grid and examined by a transmission electron microscope (TEM, JEM-2100, JEOL Ltd., Japan). Ultraviolet--visible (UV--vis) and fluorescence spectra of CDs-LP in pure water or phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 10.1 mM Na~2~HPO~4~, 1.7 mM KH~2~PO~4~, pH 7.4) were obtained by a UV--vis spectrophotometer (UV-2600, Shimadzu, Japan) and a spectrofluorophotometer (RF-5301PC, Shimadzu, Japan), respectively. Fourier transform infrared (FTIR) spectroscopic experiment was carried out with an FTIR spectrometer (Nicolet iS50, Thermo Scientific, USA). X-ray photoelectron spectroscopic (XPS) experiment was performed via a Japan Kratos Axis Ultra HAS spectrometer. Zeta potential values of CDs-LP were determined with a Zetasizer instrument (Malvern Instruments, Nano ZS, United Kingdom). The fluorescence quantum yield (QY) of the CDs-LP was calculated according to the method previously reported (Yang et al., [@B51]).

Inhibition of *E. coli* biofilm formation
-----------------------------------------

Bacteria were cultured overnight in LB at 37°C with 180 rpm. The overnight bacterial cell culture was diluted 1:100 in 1/5 LB without and with different concentrations of CDs-LP and then inoculated into the 96-well plates (Costar, Corning, USA) with 100 uL/well or the glass bottom cell culture dish (NEST, USA) with 2 mL/dish. The inoculated 96-well plates and dishes were incubated for 1--5 days at 28°C without shaking (Jurcisek et al., [@B24]; Duncan et al., [@B10]).

Confocal imaging
----------------

For confocal imaging, static biofilm was cultured and processed inside glass bottom culture dishes (Nest, USA) following the methods as described above. The grown biofilms were washed with PBS three times, stained with a live/dead assay (Filmtracer LIVE/DEAD Biofilm Viability Kit, Thermo Fisher Scientific) and then examined under a confocal microscope (TCS SP8, Leica, Germany). Fluorescence images were acquired with excitation at 488 nm, and the corresponding emissions were detected at 500 and 635 nm, respectively.

Crystal violet assay
--------------------

Static biofilm formed and processed as described above was carefully washed three times with PBS (Jurcisek et al., [@B24]; Duncan et al., [@B10]). The biofilm was heat-fixed at 60°C for 1 h, stained with crystal violet for 10 min, and then rinsed with Milli-Q water until rinse water was clear. After removing residual fluid, the stained biofilm was photographed or solubilized in the destaining solution (10% methanol and 7.5% acetic acid in water). The absorbance at 595 nm was read on a microplate reader (Multiskan, Thermo Scientific). The experiments were carried out with eight biological replicates.

Effect of CDs-LP on *E. coli* growth
------------------------------------

Bacteria were cultured overnight in LB at 37°C with 180 rpm. The overnight bacterial cell culture was diluted 1:100 in 1/5 lysogeny broth (LB) without and with different concentrations of CDs-LP and then inoculated into the 96-well plates (Costar, Corning, USA) with 100 uL/well. The inoculated 96-well plates and dishes were incubated for 24 h at 28°C without shaking. Before measuring the optical density (OD) at 600 nm, the cultured bacteria were well resuspended by pipetting up and down, and then the OD at 600 nm was recorded.

In addition, colony forming unit (CFU) counting method (plate count method) was utilized to evaluate the cytotoxicity of CDs-LP to *E. coli*. Briefly, *E. coli* in log phase were cultured in 1/5 LB containing 6 mg/mL CDs-LP at 28°C for 24 h. Each culture was diluted with 1/5 LB with a dilution factor of 1 × 10^5^. Then the diluted microbial cells were plated in triplicate on LB agar plates and cultured at 37°C for 24 h. Finally, the cell colonies of *E. coli* were counted. Three biological replicates were performed. The cytotoxicity was evaluated by comparing the number of CFUs in treated groups to that in the control group.

MTT assay
---------

AT II cells (normal lung cells) were cultured at 37°C with 5% CO~2~ in DMEM cell media supplemented with 10% fetal bovine serum. The cells (5 × 10^4^ cells per well) were seeded into a 96-well plate, cultured overnight and then treated with different concentrations of CDs-LP (0, 0.01, 0.05, 0.1, 0.5, 1, 3, and 6 mg/mL) for 24 h. 10 μL 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, 5 mg/mL) was added to each well. After incubation for 4 h, the culture medium in each well was replaced with 150 μL dimethyl sulfoxide (DMSO). The absorbance at 492 nm was recorded by a Multiskan FC microplate photometer (Thermo).

Results and discussion {#s3}
======================

Preparation and characterization of carbon dots
-----------------------------------------------

*L. plantarum* LLC-605 is a highly exopolysaccharide-producing strain (Li et al., [@B30]), and might contain a great number of carbohydrates, which can serve as abundant precursors for carbon dots formation together with other biological molecules like proteins and peptides in the bacterium. Furthermore, it belongs to lactic acid bacteria that have healthy benefits for humans. Therefore, carbon dots were fabricated using *L. plantarum* LLC-605 via one-step hydrothermal carbonization, which is denoted as CDs-LP. CDs-LP were quasi-spherical with an average diameter of 3 nm as demonstrated in the TEM image (Figure [1A](#F1){ref-type="fig"}). A crystalline structure can be observed in the high-resolution image of CDs-LP with the lattice fringe of 0.32 nm, in consistent with the (002) spacing reported for graphitic carbon (Reckmeier et al., [@B41]) (Figure [1B](#F1){ref-type="fig"}). CDs-LP could be homogeneously dispersed in aqueous solution and emitted blue fluorescence under 365 nm UV light irradiation (Figure [1C](#F1){ref-type="fig"}). Besides, no characteristic absorption peak was found in the UV-vis spectrum of CDs-LP, which was also observed in other carbon nanomaterials (Zhao et al., [@B55]; Jiang et al., [@B22]; Lin et al., [@B33]). The synthesis mechanism of CDs remains obscure, which might involve decomposing and carbonization of stocks, dehydration condensation, nucleation and growth of carbon in the progress of hydrothermal experiments (Reckmeier et al., [@B41]).

![Characterization of CDs-LP. **(A)** TEM image and the corresponding size distribution histogram of CDs-LP (inset). **(B)** The high-resolution TEM image of CDs-LP. **(C)** UV--vis absorption spectra of CDs-LP in water. The insets are photographs of CDs-LP in water with and without irradiation under a 365 nm UV lamp. **(D)** Fluorescence spectra of CDs-LP dispersed in water. **(E)** FTIR spectra of dried CDs-LP. **(F)** XPS spectrum of dried CDs-LP and the high-resolution XPS peaks of C1s **(G)**, N1s **(H)** and O1s **(I)**.](fmicb-09-00259-g0001){#F1}

The quantum yield (QY) of CDs-LP was 10.3%. CDs-LP has a largely negative charge with a zeta potential of −22 mV, which might due to that its raw material L. plantarum LLC-605 is negatively charged. The emission intensity of CDs-LP increased gradually from 300 nm to 380 nm, and then declined from 400 to 520 nm (Figure [1D](#F1){ref-type="fig"}). Meanwhile, the emission peaks of CDs-LP gradually red-shifted from 420 to 540 nm when the excitation wavelength varied from 300 to 520 nm (Figure [1D](#F1){ref-type="fig"}). The maximum emission peak was at 450 nm with the excitation wavelength of 380 nm. Obviously, the fluorescence emission spectrum of CDs-LP is dependent on the excitation wavelength. Although the mechanism behind the red-shift emission property that harbored by a great number of the reported carbon dots (Wang and Zhou, [@B47]; Yang et al., [@B50]; Hua et al., [@B21]) is still not clear, it is often associated with surface- or defect states in the amorphous carbon shell of CDs near the Fermi level (Reckmeier et al., [@B41]; Hua et al., [@B21]).

FITR and XPS were utilized to investigate the composition of CDs-LP. As shown in Figure [1E](#F1){ref-type="fig"}, the broad absorption band around 3,188 cm^−1^ was due to the stretching vibrations of O--H (ν(O--H)) and/or N--H (ν(N--H)). The peak at 1,674 cm^−1^ belongs to the C = O stretching vibration, ν(C = O), which may come from the amide bond (--CONH--) or the --COOH group. The peak at 1,593 cm^−1^ is attributable to the N--H bending vibration δ(N--H), owing to the amide bond (--CONH--) or the NH~2~ group. The peak at 1,405 cm^−1^ may derive from the C--H bending vibration (δ(C--H)), and the peak at 1,124 cm^−1^ can be assigned to the C--O stretching vibration (ν(C--O)). CDs-LP contain the elements of C (70.7%), O (17.9%), N (10.9%), P (0.2%), and S (0.2%) as measured by XPS (Figure [1F](#F1){ref-type="fig"}). Note that the H element cannot be determined by XPS. The two fitted peaks at 285 and 287.6 eV in the high-resolution C1s spectrum (Figure [1G](#F1){ref-type="fig"}) can be assigned to carbon-containing groups C--C/C = C (sp2 carbons) and C = O, respectively (Bao et al., [@B3]). The N1s peak at 399.7 and 401.5 eV (Figure [1H](#F1){ref-type="fig"}) could separately be ascribed to amide nitrogen C-N-C and the amino nitrogen N-H (Yang et al., [@B52]; Zhang and Chen, [@B53]), evidencing the presence of both amino and amido groups in CDs-LP as found by FTIR. For the O1s spectrum, the fitted peak at 531.5 eV (Figure [1I](#F1){ref-type="fig"}) is attributed to the oxygen element in the form of C--O (Zhang and Chen, [@B53]; Ding et al., [@B9]). In conclusion, the FTIR and XPS results showed that the as-synthesized CDs-LP contain the elements C, H, O, N, P, and S, and the functional groups --OH, --COOH, --NH~2~, and --CONH--.

CDs-LP inhibit the formation of *E. coli* biofilm
-------------------------------------------------

To observe how CDs-LP affect the formation of *E. coli* biofilms, various amounts of carbon dots were added into the culture media during biofilm growth and the processes of biofilm formation within 72 h were monitored by the crystal violet assay (Figure [2](#F2){ref-type="fig"}). Before being assayed by the crystal violet assay (Figure [2](#F2){ref-type="fig"}) or checked under confocal microscopy (Figure [3](#F3){ref-type="fig"}), the samples were washed three times with PBS to remove the planktonic cells. So if the biofilm formation is inhibited and the cells do not attach to the surface, the cells would be washed away, leaving fewer cells on the surface. The biofilm formation was reduced gradually from 100% to 10.2% in 24 h, as the CDs-LP concentration increased from 0 to 1 mg/mL (Figure [2A](#F2){ref-type="fig"}). When the concentration of CDs-LP was 3 mg/mL and higher, no *E. coli* biofilm was formed, showing that CDs-LP could effectively inhibit the biofilm formation of *E. coli* when the concentration is above 3 mg/mL. When the treatment time was increased from 24 to 72 h, the inhibition effect was enhanced slightly (Figure [2A](#F2){ref-type="fig"}). The mean IC50 value for biofilm inhibition (MBIC50) is defined as the lowest concentration at which at least 50% reduction in biofilm formation was achieved compared to untreated biofilm (Feldman et al., [@B12]). Here the MBIC50 of CDs-LP was measured to be 0.4 mg/mL. Moreover, the crystal violet staining results of the *E. coli* biofilms with the treatment of 0, 0.1, 0.8, and 3 mg/mL CDs-LP for 72 h are shown in Figure [2B](#F2){ref-type="fig"}. Clearly, the presence of CDs-LP significantly reduced the biofilm formation of *E. coli* at 0.1 mg/ mL and completely inhibited it at 0.8 or 3 mg/mL, which was in line with the results obtained by measuring the absorbance at 595 nm (Figure [2A](#F2){ref-type="fig"}).

![The effect of CDs-LP on the *E. coli* biofilm was assayed by the crystal violet method. The *E. coli* biofilm was grown at 28°C in 1/5 LB with the treatment of different concentrations of CDs-LP for different times as indicated in the figure. The absorbance of *E. coli* biofilm in the absence of CDs-LP at 24, 48, and 72 h after staining by the crystal violet, was recorded at 595 nm and arbitrarily assigned as 100%, respectively **(A)**. Also, the *E. coli* biofilms with the treatment of 0, 0.1, 0.8, or 3 mg/mL CDs-LP for 72 h were stained by the crystal violet and photographed **(B)**.](fmicb-09-00259-g0002){#F2}

![The 3D images of *E. coli* biofilms at 24, 48, and 72 h in the presence of 0, 0.1, 0.8, or 3 mg/mL CDs-LP were observed under a confocal laser microscope. The biofilms were stained using the live/dead stain assay. Green and red dots represent live and dead bacteria, respectively.](fmicb-09-00259-g0003){#F3}

Although carbon dots have been successfully exploited in imaging biofilm matrix (Ritenberg et al., [@B44]) and biofilm-encased microorganisms (Lin et al., [@B33]), it is for the first time to report that carbon dots can inhibit *E. coli* biofilm formation. Moreover, the synthesis of CDs-LP only requires *L. plantarum* LLC-605 as the only raw material through one-step hydrothermal reaction, which is very facile and renewable. *L. plantarum* LLC-605 belongs to lactic acid bacteria that have healthy benefits for humans. In biomedical practice, the successful prevention of bacterial biofilm formation could reduce the need for interventional treatments such as systemic and local antibiotic administration, amputation, debridement, or reconstruction, which would improve patient outcomes and reduce the costs associated with infection treatment. In industrial applications, antifouling is important for the performance and durability of the facilities, and cost saving. Therefore, the development of new biofilm inhibitors like CDs-LP here is of great value.

CDs-LP did not inhibit the growth of *E. coli*
----------------------------------------------

Confocal microscopy was utilized to evaluate the ability of CDs-LP to prevent adhesion and colonization of *E. coli*. The live and dead bacteria were stained with green and red respectively with the live/dead stain assay (Figure [3](#F3){ref-type="fig"}). After treatment with CDs-LP of 0.1 mg/mL, 0.8 mg/mL, or 3 mg/mL, the *E. coli* biofilm became thinner with a significant reduction in biovolume, as compared to the untreated control. Though several *E. coli* cells were observed on the culture dish\'s surface at 0.8 or 3 mg/mL CDs-LP concentration, they are not able to colonize and aggregate to form biofilm. Interestingly, no red fluorescence was observed (Figure [3](#F3){ref-type="fig"}), showing that there was no dead *E. coli* cells inside the biofilm and indicating CDs-LP caused no toxicity to *E. coli* cells. Seemingly, the presence of CDs-LP prevents the colonization and aggregation of *E. coli* on the surface that are prerequisites for *E. coli* biofilm formation while not killing the cells.

To further confirm that the capability of CDs-LP to inhibit biofilm formation is not due to bactericidal activity, the effect of CDs-LP on the growth of *E. coli* was tested by both optical density assay and plate count method (Figure [4](#F4){ref-type="fig"}). The OD of the *E. coli* culture remained unaltered in the presence of 0--6 mg/mL CDs-LP (Figure [4A](#F4){ref-type="fig"}). Moreover, the cell viability of *E. coli* incubated with 6 mg/mL CDs-LP for 24 h were about 103% (Figures [4B,C](#F4){ref-type="fig"}). These results demonstrate that CDs-LP did not block the *E. coli* growth, which is well correlated with the data obtained by the live/dead assay (Figure [3](#F3){ref-type="fig"}). Obviously, the anti-*E. coli* biofilm property of CDs-LP was not attributed to a bactericidal effect, which would be beneficial for the growth of natural bacterial flora. Identification of anti-biofilm compounds that prevent biofilm formation without killing bacteria will provide a much flexible and practical solution to biofilm infections, because such an approach will not interfere the other non-infectious and natural bacterial flora which are crucial for human and ecosystems. Meanwhile, antifouling coatings nontoxic to marine biota, such as silicone elastomers (Phanindhar et al., [@B40]) and vanadium pentoxide nanowires (Natalio et al., [@B37]), have been of great interest, for they do not cause deleterious effects in aquatic environments and are environmentally benign (Lejars et al., [@B29]). In addition, the non-bactericidal property of CDs-LP implies that the application of CDs-LP in anti-biofilm should not lead to antibiotic resistance that long haunts antibiotic-based antibiofilm agents. When it is necessary to kill microorganisms, CDs-LP can be simultaneously used in combination with antibiotics. Therefore, preventing *E. coli* biofilm formation by CDs-LP represents a neutral and flexible strategy.

![Effect of CDs-LP on *E. coli* growth. **(A)** Growth of *E. coli* for 24 h in 1/5 LB containing 0-6 mg/mL CDs-LP at 28°C without shaking. The absorbance of *E. coli* cell culture in the absence of CDs-LP was measured at 600 nm and arbitrarily defined as 100%. **(B)** Photographs of the agar plates and **(C)** corresponding statistical histograms of colonies of *E. coli* cultured in 1/5 LB (control) and CDs-LP (6 mg/mL) for 24 h.](fmicb-09-00259-g0004){#F4}

The CDs-LP is non-toxic toward animal cells
-------------------------------------------

To evaluate the safety of CDs-LP, which is important for both biomedical and industrial applications, the relative viabilities of AT II cell with the treatment of CDs-LP in the range from 0 to 6 mg/mL were measured (Figure [5](#F5){ref-type="fig"}). More than 80% of AT II cells remained alive under all the tested concentrations of CDs-LP in the range of 0--6 mg/mL, implying that CDs-LP is non-toxic within the concentrations that are utilized to inhibit *E. coli* biofilm formation. The formation of *E. coli* biofilm was inhibited completely by CDs-LP at 1 mg/mL and higher concentrations. Given that CDs-LP are negatively charged and CDs are well known for their excellent biocompatibility, it is reasonable that CDs-LP did not affect the growth and viability of neither bacteria nor the animal cells.

![*In vitro* safety testing result of CDs-LP. Relative viabilities of AT II cell exposed to different concentrations of CDs-LP were determined by MTT assay. The absorbance of AT II cells in the absence of CDs-LP was measured at 492 nm and arbitrarily assigned as 100%.](fmicb-09-00259-g0005){#F5}

Several biofilm inhibitors have been reported to be non-toxic to *E. coli* and other bacteria as well as animal cells, such as (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone (furanone) (Ren et al., [@B42]), ursolic acid (Ren et al., [@B43]), 5-fluorouracil(Attila et al., [@B2]), indole derivatives (Lee et al., [@B28], [@B26], [@B27]) and cationic pillararenes (Joseph et al., [@B23]). They inhibit the biofilm formation through cell signaling, sulfur metabolism (Wood, [@B49]) or cysteine metabolism (Lee et al., [@B28]). Most of these biofilm inhibitors are natural compounds that are not easy to obtain due to scarce resources, while others are synthesized with complicated chemical/physical methods that are not easy to scale up. Contrarily, here the synthesis of CDs-LP is simple, fast and in large amount using the raw material strain LCC605 that is easily accessible. Furthermore, there are active functional groups on CDs-LP surfaces as detected by FTIR and XPS, allowing for further surface engineering to achieve desirable surface coating and bactericidal property.

Most of the current anti-biofilm nanomaterials exhibit potential cytotoxicity and poor biocompatibility, which is mainly caused by the positive charge of cationic nanomaterials that can interact with the negatively charged bacteria/mammalian cell surface through electrostatic interaction. Surface engineering has been often explored to solve this issue. For example, carbon nano/microspheres have been combined with metal nanoparticles to reduce their toxicity and improve their stability (Cui et al., [@B7]; Li et al., [@B32]; Cheng et al., [@B6]). The surface charge of gold nanoparticles was modulated to achieve specific toxicity toward bacterial biofilms while minimizing mammalian cytotoxicity (Giri et al., [@B17]). Healthy tissues under generally physiological conditions have a pH of \~7.4, whereas biofilm is acidic with a pH of \~5.5. Therefore nanoparticles were modified with pH-responsive moieties that enable specific target of biofilm and/or drug release at acidic pH found within biofilm, leading to highly efficient antibiofilm activity without damaging the tissues around biofilm (Horev et al., [@B18]; Liu et al., [@B34]; Hu et al., [@B19]). Clearly, these surface engineering strategies usually involved complicated chemical/physical modifications. Conversely, the one-step hydrothermal synthesis of CDs-LP reported here is very simple. Given that the most-explored metal-containing nanomaterials for biofilm treatment have potential cytotoxicity and poor biocompatibility, it is of great importance to develop the metal-free, carbon-based materials that are less toxic and more biocompatible, as demonstrated by CDs-LP in our study.

CDs-LP did not show bactericidal activity toward *E. coli*, but it could significantly reduce the colonization and aggregation of *E. coli* on the surface that are essential for *E. coli* biofilm formation. Instead of preventing biofilm formation through disrupting cell membranes and killing bacteria by many nanomaterials which might cause cytotoxicity (Cui et al., [@B7]; Li et al., [@B32]; Cheng et al., [@B6]; Giri et al., [@B17]; Horev et al., [@B18]; Liu et al., [@B34]; Hu et al., [@B19]), here CDs-LP likely inhibit the biofilm formation through cell signaling (Wood, [@B49]), sulfur metabolism(Wood, [@B49]) or cysteine metabolism (Lee et al., [@B28]), as found for other non-toxic biofilm inhibitors. However, it is not unclear how and which signal pathways in *E. coli* are affected by CDs-LP and involved in the biofilm inhibition. Further detailed study is required but beyond the scope of this research.

Conclusion {#s4}
==========

In this study, a new type of carbon dots, CDs-LP, was synthesized by one-step hydrothermal carbonization of *L. plantarum* LLC-605, which is facile, fast, cheap, and green. CDs-LP are capable of inhibiting *E. coli* biofilm formation. Most importantly, CDs-LP did not inhibit the growth of *E. coli* and mammalian cells, preventing the generation of bacteria drug-resistance and presenting great biocompatibility. CDs-LP represent a novel kind of non-toxic anti-biofilm materials to circumvent the cytotoxicity faced by many current anti-biofilm agents, holding great promise for eco-friendly applications against *E. coli* biofilm formation for both microbial infection treatment and anti-biofouling material development.
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